Literature DB >> 9563733

Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients.

E Girou1, F Stephan, A Novara, M Safar, J Y Fagon.   

Abstract

Intensive-care-unit (ICU) patients are at risk for both acquiring nosocomial infection and dying, and require a high level of therapy whether infection occurs or not. The objective of the present study was to precisely define the interrelationships between underlying disease, severity of illness, therapeutic activity, and nosocomial infections in ICU patients, and their respective influences on these patients' outcome. In a 10-bed medical ICU, we conducted a case-control study with matching for initial severity of illness, with daily monitoring of severity of illness and therapeutic activity scores, and with analysis of the contribution of nosocomial infections to patients' outcomes. Forty-one cases of patients who developed nosocomial infections during a 1-yr period were paired with 41 controls without nosocomial infection according to three criteria: age (+/- 5 yr), Acute Physiology and Chronic Health Evaluation II (APACHE II) score (+/- 5 points), and duration of exposure to risk. Successful matching was achieved for 118 of 123 (96%) variables. Neurologic failure on the third day after ICU admission was the sole independent risk factor for nosocomial infection (adjusted odds ratio [OR]: 1.34; 95% confidence interval [CI]: 1.09 to 1.64; p = 0.007). Unlike control patients, case patients showed no clinical improvement and required a high level of therapeutic activity between ICU admission and the day of infection. Mortality attributable to nosocomial infection was 44%. Excess length of stay and duration of antibiotic treatment attributable to nosocomial infection were 14 d and 10 d, respectively. Attributable therapeutic activity as measured with the Therapeutic Intervention Scoring System (TISS) and Omega score was 368 and 233 points, respectively. Such consequences were observed in patients who developed multiple infections. These findings suggest that a persistent high level of therapeutic activity and persistent impaired consciousness are risk factors for nosocomial infections in ICU patients. These infections are responsible for excess mortality, prolongation of stay, and excess therapeutic activity resulting in important cost overruns for health-care systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563733     DOI: 10.1164/ajrccm.157.4.9701129

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  41 in total

1.  Using the six sigma process to implement the Centers for Disease Control and Prevention Guideline for Hand Hygiene in 4 intensive care units.

Authors:  Noel E Eldridge; Susan S Woods; Robert S Bonello; Kay Clutter; Leann Ellingson; Mary Ann Harris; Barbara K Livingston; James P Bagian; Linda H Danko; Edward J Dunn; Renee L Parlier; Cheryl Pederson; Kim J Reichling; Gary A Roselle; Steven M Wright
Journal:  J Gen Intern Med       Date:  2006-02       Impact factor: 5.128

2.  Invasive devices: no need? No use!

Authors:  Stijn I Blot; Renaat Peleman; Koenraad H Vandewoude
Journal:  Intensive Care Med       Date:  2006-12-05       Impact factor: 17.440

3.  Effect of guideline implementation on costs of hand hygiene.

Authors:  Patricia W Stone; Sumya Hasan; Dave Quiros; Elaine L Larson
Journal:  Nurs Econ       Date:  2007 Sep-Oct       Impact factor: 1.085

4.  ICU-acquired infections and sepsis: more of a deadly duo.

Authors:  Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2008-02-08       Impact factor: 17.440

5.  The Severity of ICU-Acquired Pneumonia.

Authors:  Hugues Marechal; Nathalie Layios; Pierre Damas
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

6.  Factors influencing the length of hospitalisation in intensive care units: a prospective observational study.

Authors:  Franca Vacca; Monica Vaiani; Andrea Messori; Sabrina Trippoli; Susanna Maltoni; Filippo Pelaotti; Benedetta Santarlasci; Filippo Bardelli
Journal:  Pharm World Sci       Date:  2004-10

7.  Benefits and risks of success or failure of noninvasive ventilation.

Authors:  Alexandre Demoule; Emmanuelle Girou; Jean-Christophe Richard; Solenne Taille; Laurent Brochard
Journal:  Intensive Care Med       Date:  2006-09-21       Impact factor: 17.440

Review 8.  Meropenem: a review of its use in patients in intensive care.

Authors:  M Hurst; H M Lamb
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

9.  Nicotine withdrawal and agitation in ventilated critically ill patients.

Authors:  Olivier Lucidarme; Amélie Seguin; Cédric Daubin; Michel Ramakers; Nicolas Terzi; Patrice Beck; Pierre Charbonneau; Damien du Cheyron
Journal:  Crit Care       Date:  2010-04-09       Impact factor: 9.097

10.  A continuous quality-improvement program reduces nosocomial infection rates in the ICU.

Authors:  Benoit Misset; Jean-François Timsit; Marie-Françoise Dumay; Maité Garrouste; Annie Chalfine; Isabelle Flouriot; Fred Goldstein; Jean Carlet
Journal:  Intensive Care Med       Date:  2003-12-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.